• Users Online: 421
  • Print this page
  • Email this page
Year : 2020  |  Volume : 34  |  Issue : 2  |  Page : 78-83

A retrospective study of chart review for the use of benzodiazepines and related drugs among patients with dementia

1 Department of Geriatric Psychiatry, Taoyuan Psychiatric Center, Taoyuan, Taiwan
2 Department of Geriatric Psychiatry, Taoyuan Psychiatric Center, Taoyuan; Department of Psychiatry, National Taiwan University Hospital and School of Medicine, National Taiwan University, Taipei, Taiwan

Correspondence Address:
Hung- Yu Chan
No. 71, Longshou Street, Taoyuan 33058, Taoyuan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/TPSY.TPSY_20_20

Rights and Permissions

Objective: Benzodiazepines and related drugs (BZDRs) increase the risk of undesirable health outcomes in the elderly and should be prescribed judiciously. In this study, we intended to evaluate the prevalence of BZDRs among patients with dementia and to identify the risks associated with BZDR use. Methods: This study was conducted at a public psychiatric hospital in northern Taiwan. Patients with Taiwan National Health Insurance catastrophic illness certificate of dementia were recruited. We reviewed their medical records for a two-year period since the issued date of patients' certificates. Results: The prevalence of BZDRs among the patients with dementia was up to 49% (151/308). The most popular BZDRs in this study were estazolam (16.2%), followed by zopiclone (11.4%) and zolpidem (7.5%). The most common adverse events (AEs) related to BZDRs were delirium (6.0%), followed by somnolence (4.6%) and fall (2.0%). Patients with physical comorbidities had significantly higher risk of BZDR-related AEs compared to those without physical comorbidities (adjusted odds ratio = 2.097, 95% confidence interval = 1.225–3.589, p < 0.05). Conclusion: In this study, we identified that BZDRs were highly prevalent in patients with dementia and physical comorbidities, that BZDRs were associated with higher risk of AEs, and that delirium, somnolence, and fall were common AEs during the period of BZDR treatment. Clinicians should be aware of the AEs of BZDRs and prescribe BZDRs carefully for older-demented patients.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded85    
    Comments [Add]    

Recommend this journal